Description
MLN2480 is an oral pan-Raf inhibitor designed to inhibit cell proliferation and survival. MLN2480 is currently in clinical trials and displays anticancer chemotherapeutic activity.
Product Unit Size | Cost | Quantity | Stock |
---|
MLN2480 is an oral pan-Raf inhibitor designed to inhibit cell proliferation and survival. MLN2480 is currently in clinical trials and displays anticancer chemotherapeutic activity.
Cas No. | 1096708-71-2 |
---|---|
Purity | ≥98% |
Formula | C17H12Cl2F3N7O2S |
Formula Wt. | 506.30 |
IUPAC Name | 2-[(1R)-1-[(6-amino-5-chloropyrimidine-4-carbonyl)amino]ethyl]-N-[5- chloro-4-(trifluoromethyl)pyridin-2-yl]-1,3-thiazole-5-carboxamide |
Solubility | DMSO 100 mg/mL (197.51 mM) Ethanol 100 mg/mL (197.51 mM) Water Insoluble |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
MSDS | |
---|---|
Info Sheet | |
Brochures |
http://clinicaltrials.gov/show/NCT01425008
Potential ATP-sensitive K+ channel blocker, pot...
Active isomer of epinephrine, endogenous hormon...
Tropane alkaloid found in plants in the Solanac...
PDE5 inhibitor.
14α-demethylase inhibitor.
EGFR inhibitor.
AhR agonist, dihydroorotate dehydrogenase inhib...
Hormonal attractant for male Bactrocera flies.<...
Alkaloid originally found in species of Aconitu...
Decreases expression of MMPs, PGE2, and COX-2, ...
Enalapril analog; ACE inhibitor.
Extract containing catechins and flavonoids fou...
Melanoma-associated antigen.
SIRT inhibitor.
Endogenous APP peptide cleavage product, primar...
NSAID; COX-1/2 and lipoxygenase inhibitor.
BACE1 inhibitor
PI3K and mTOR inhibitor.
LBQ657 prodrug; neprilysin inhibitor.
ERK1/2 inhibitor.